금융 뉴스 허브

CarMax is learning from past mistakes—J.P. Morgan

Chip stocks are entering a seasonal downturn, and it could affect the broader market – analyst

Associated Banc-Corp 5.625 DP PF SR F declares $0.3515 dividend

SpaceX stock back under pressure as Q2 earnings approach

SpaceX stock came back under pressure Wednesday, reversing yesterday's bounce, as a broader market and tech selloff adds to investor caution ahead of SpaceX's first earnings report.

SpaceX Is Worth More Than Most S&P 500 Companies. Is That Valuation Rational?

The company's mission to establish humanity on other planets has fired up the investment community.

AMREP Stock Slips Post Q4 Earnings, Net Income Declines

AXR's strong home sales, improved margins and liquidity position highlight key drivers shaping its fiscal 2026 performance and outlook.

Federal Reserve: Hawkish hold may offer US Dollar limited support – BNY

BNY’s Geoff Yu highlights that markets face a genuinely live Federal Reserve (Fed) decision, with futures implying about a 35% chance of a hike and a hold still the base case.

Veralto's Q2 Earnings Beat Estimates, Increase Year Over Year

VLTO's Q2 earnings and sales top estimates as Water Quality leads growth, tariff refunds lift profit and 2026 guidance is raised.

Dow Tumbles Over 850 Points – Trump's Latest Iran Warning Sends Crude Oil Prices Soaring Ahead Of Fed Decision

During an interview with Fox News on Wednesday, Trump warned that the United States will be “hitting Iran hard” following the attack on U.S. bases in Jordan.

How Far Tesla Stock Needs to Fall to Lose Trillion-Dollar Status

The shares dropped for five consecutive days, including a four-day losing streak since the car maker reported weaker-than-expected second-quarter earnings.

S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings

GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to pro ...

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.